A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01849874 |
|
Recruitment Status :
Active, not recruiting
First Posted : May 9, 2013
Last Update Posted : April 19, 2018
|
Sponsor:
Array BioPharma
Information provided by (Responsible Party):
Array BioPharma
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | April 1, 2016 |
| Estimated Study Completion Date : | September 30, 2018 |
| Certification/Extension First Submitted : | April 3, 2017 |